Abstract
Genetic polymorphisms of drug-metabolizing enzymes give rise to distinct subgroups in the population which differ in their ability to perform a certain drug biotransformation reaction. Genetic polymorphisms thus contribute considerably to interindividual variation in drug response. Individuals with genetically impaired metabolism are usually designated as poor metabolizers, as compared to normal or extensive metabolizers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
